01022nam0-2200301 --450 991050759080332120211203135342.020211203d1988----kmuy0itay5050 bagerDE 001yyVocabularius ex quouberlieferungsgeschichtliche Ausgabegemeinsam mit Klaus Grubmullerherausgegeben von Bernhard Schnell ... <et al.>TubingenNiemeyer1988-v.25 cmv. 1: Einleitung; v. 2: Text A-C; v. 3: Text D-K; v. 4: Text L-P; v. 5: Text Q-ZGrubmuller,Klaus199665Schnell,BernhardITUNINAREICATUNIMARCBK9910507590803321477.002 VOC 1 (1)8092FLFBC477.002 VOC 1 (2)8092FLFBC477.002 VOC 1 (3)8092FLFBC477.002 VOC 1 (4)8092FLFBC477.002 VOC 1 (5)8092FLFBCFLFBCVocabularius ex quo526485UNINA03800nam 2200649Ia 450 991013986390332120170810173306.01-282-29203-X97866122920331-4443-1588-91-4443-1589-7(CKB)1000000000794414(EBL)456013(OCoLC)458488203(SSID)ssj0000130780(PQKBManifestationID)11132566(PQKBTitleCode)TC0000130780(PQKBWorkID)10084969(PQKB)10349536(MiAaPQ)EBC456013(EXLCZ)99100000000079441420090415d2009 uy 0engur|n|---|||||txtccrCorporate boards[electronic resource] managers of risk, sources of risk /edited by Robert W. Kolb and Donald SchwartzChichester ;Malden, MA Wiley-Blackwell20091 online resource (397 p.)Loyola University series on riskDescription based upon print version of record.1-4051-8585-6 Includes bibliographical references and index.CORPORATE BOARDS; Contents; Notes on Contributors; Preface; Introduction; Part I A Factual Basis; 1 The Relationship Between Boards of Directors and their Risk Management Organizations: Are Standards of Best Practice Emerging?; Part II Is Risk Management by Corporate Boards Even Possible?; 2 Risk Management, Chaos Theory, and the Corporate Board of Directors; 3 Anti-Social Norms, Risky Behavior; 4 Time-Inconsistent Boards and the Risk of Repeated Misconduct; 5 Discussion; Part III Board Structure and the Management of Risk; 6 Theories of Governance and Corporate Moral Vulnerability7 Mitigating the Exposure of Corporate Boards to Risk and Unethical Conflicts8 Supervisory Board and Financial Risk-Taking Behaviors in Chinese Listed Companies; 9 Discussion; Part IV Corporate Boards and the Management of Specific Risks; 10 Entity-Level Controls and the Monitoring Role of Corporate Boards; 11 Do Corporate Boards Care About Sustainability? Should They Care?; 12 Executive Risk Taking and Equity Compensation in the M&A Process; 13 Discussion; Part V Corporate Boards, Risk Management, and the Ethical Firm; 14 The Ethics of Risk Management by a Board of Directors15 Assurance and Reassurance: The Role of the Board16 Risk Disclosure and Transparency: Toward Corporate Collective and Collaborative Informed Consent; 17 Discussion; IndexCorporate Boards: Managers of Risk, Sources of Risk deals with the highly timely topic of the Corporate Board and its relationship to risk, both in terms of its management and its creation. Utilizes a multi-disciplinary perspective which draws on the fields of economics, law, business ethics, and corporate social responsibilityFeatures a range of topics including the role of corporate boards in overseeing increasingly complex risk management techniques and the ethical dimensions of corporate board behavior in managing risk Of interest to students, scholarLoyola University Series on Risk ManagementBoards of directorsCorporate governanceRisk managementElectronic books.Boards of directors.Corporate governance.Risk management.658.155658.422Kolb Robert W.1949-891740Schwartz Donald E.1930-982674MiAaPQMiAaPQMiAaPQBOOK9910139863903321Corporate boards2242612UNINA02993nam 2200601 450 991079090190332120230803221413.00-19-935893-10-19-935892-3(CKB)2550000001302380(EBL)1685687(OCoLC)880147859(SSID)ssj0001197096(PQKBManifestationID)12455274(PQKBTitleCode)TC0001197096(PQKBWorkID)11177517(PQKB)10225082(MiAaPQ)EBC1685687(Au-PeEL)EBL1685687(CaPaEBR)ebr10871676(CaONFJC)MIL611021(EXLCZ)99255000000130238020140526h20142014 uy 0engur|n|---|||||txtccrUnderstanding antiepileptic drugs guiding you through the maze of options /Bernd Pohlmann-Eden, Bernhard J. Steinhoff ; translation by Klaus C. HoferNew York, New York :Oxford University Press,2014.©20141 online resource (185 p.)Includes index.0-19-935891-5 1-306-79770-5 ""Cover""; ""Understanding Antiepileptic Drugs""; ""Copyright""; ""CONTENTS""; ""PREFACE: FIRST ENGLISH EDITION""; ""PREFACE: FIFTH GERMAN EDITION""; ""FOREWORD""; ""INTRODUCTION""; ""Specific Profiles of Antiepileptic Drugs (in alphabetical order)""; ""Carbamazepine""; ""Clobazam""; ""Eslicarbazepine Acetate""; ""Ethosuximide""; ""Felbamate""; ""Gabapentin""; ""Lacosamide""; ""Lamotrigine""; ""Levetiracetam""; ""Oxcarbazepine""; ""Perampanel""; ""Phenobarbital/Primidone""; ""Phenytoin""; ""Pregabalin""; ""Retigabine""; ""Rufinamide""; ""Stiripentol""; ""Tiagabine""; ""Topiramate""""Valproic Acid/Valproate/Divalproex Sodium""""Vigabatrin""; ""Zonisamide""; ""Index""Understanding Antiepileptic Drugs enhances patient knowledge and to acts as a facilitator to fill a significant gap in patient-physician communication in the field of epilepsy. There are several studies which show evidence that compliance in taking medication is absolutely crucial for successful medical treatment. A precondition for compliance, in addition to a trusting patient-physician relationship, is the ability to understand the medication under discussion and to be competent to be able to ask the right questions of your doctor. The ultimate goal should be to make the patient the expert oEpilepsyTreatmentAnticonvulsantsEpilepsyTreatment.Anticonvulsants.615.784Pohlmann-Eden Bernd1539609Steinhoff Bernhard J.Hofer Klaus C.MiAaPQMiAaPQMiAaPQBOOK9910790901903321Understanding antiepileptic drugs3790570UNINA